LG's human growth hormone Valtropin sales approved in Europe

Published: 2006-05-18 06:59:00

Updated: 2006-05-18 06:59:00

LG Life Science announced that the company completed the European health registration for "Human Growth Hormone" under the trademark of Valtropin (daily dosage form), which was developed by the Korean own technologies, through the company strategic business partner, BioPartner Inc. on April 26.

Valtropin (Utropin in Korea) was first succeeded in its production by local bio-engineering techno...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.